News & Announcements

Webinar: Harmonizing and Curating Raw Data to Streamline SDTMs

Date: 19-Jan-2023
Timing: 12:00 PM ET (0900 AM West Coast)

Upcoming Webinar

Title: Harmonizing and Curating Raw Data to Streamline SDTMs

Society of Toxicology

Date and Time: March 29th at 1:30pm PT
Room: 23A
San Diego, CA.

PointCross held a panel discussion with senior industry partners at the Society of Toxicology conference in March 2022 discussing the implications of interim study monitoring, including the time and cost savings achievable by having a subject’s in-life, necropsy, and pathology findings available in digital format sooner than the final study report.

More information on Interim Study Monitoring can be found here.

Register for Webinar

Date: Tuesday, October 19th, 2021

PhUSE US Connect

June 2021

Poster Presentation :

Integrating Clinical Data for Translational Research

Enabling Data Integration for Translational & Precision Medicine

May 2021

PointCross’s Xbiom Clinical Insights Module is designed for Translational Medicine Teams to curate, harmonize, and standardize disparate assay data and EDC study data from clinical trials, along with genotyping data, molecular, and other biomarker data. Our newly launched Data Concierge Service helps shoulder the burden of data wrangling by integrating directly with your CROs and external labs to help close the gap between these disparate data sources and rendering study data fit-for-use by scientists and researchers for longitudinal analysis, cross-domain search, and stratified cohort selection based on patient history, consent availability, specific molecular biomarkers, study type, and more.


Success For Our Valued Customers

We thank our customers for their trust shown in us and take pride in our accomplishments.

Global Team
US – India – Europe
5 of top 15 Pharma Clients
10+ Years Experience in Life Science

We are a global technology company providing the life sciences industry solutions in big data analytics, management, visualization, and warehousing. Our offerings reduce risks, prove data quality, shorten time to market, and generate better insights from R&D and regulatory data.

Our Vision

Let's Talk